More than 12,000 new medicines in pipeline in 2023, up 31% from previous year: reportOf the 12,203 drugs in the pipeline, 5,319 were in Phase 1 while 4,979 were in Phase 2. In addition, there were 1,671 Phase 3 drugs and 234 in the pre-registration stage. Pet pharmaceuticals: Action needed to combat lack of competition, report saysCompetition Bureau calls on provinces and territories to consider mandating the supply of pet medication to allow pharmacists to enter the growing market. What should reform of PPNs in Ontario look like? The consultation period is over—will Ontario take any of the advice given by pharmacy stakeholders? Innovators: Compound interest Addressing patient needs and filling gaps for other pharmacies pays off for Create Compounding Pharmacy. Pharmacy Association of Nova Scotia announces award winners The annual PANS Awards Gala is dedicated to celebrating and spotlighting the achievements of outstanding pharmacy professionals throughout the province. Cabtreo gel is the first topical triple-therapy combination product for acne The three ingredients—clindamycin, adapalene and benzoyl peroxide—have complementary mechanisms of action targeting the pathology of acne vulgaris. Overuse of oral corticosteroids is common among Canadian patients with severe asthma Frequent or prolonged OCS use can pose substantial health risks, but there are other options for severe asthma. A ‘clinical graveyard’ no more? Research offers hope in treating refractory glioblastoma Treatment in mouse model doubled survival time. This PharmaChoice member dropped PrescribeIT—will others follow? The proposed 20-cent transaction fee for PrescribeIT for new and renewal electronic prescriptions is set to take effect in January. Senescence One of the obstacles to retiring from medical practice is the perception that it immediately renders you ‘old.’ First Previous 4 5 6 7 8 Next Last
